Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis

MLA

Valentina Maria Sofia, et al. “Trans-Heterozygosity for Mutations Enhances the Risk of Recurrent/Chronic Pancreatitis in Patients with Cystic Fibrosis.” Molecular Medicine, vol. 24, no. 1, July 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s10020-018-0041-6.

APA

Valentina Maria Sofia, Cecilia Surace, Vito Terlizzi, Letizia Da Sacco, Federico Alghisi, Antonella Angiolillo, Cesare Braggion, Natalia Cirilli, Carla Colombo, Antonella Di Lullo, Rita Padoan, Serena Quattrucci, Valeria Raia, Giuseppe Tuccio, Federica Zarrilli, Anna Cristina Tomaiuolo, Antonio Novelli, Vincenzina Lucidi, Marco Lucarelli, … Adriano Angioni. (2018). Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis. Molecular Medicine, 24(1), 1–10. https://doi.org/10.1186/s10020-018-0041-6

Chicago

Valentina Maria Sofia, Cecilia Surace, Vito Terlizzi, Letizia Da Sacco, Federico Alghisi, Antonella Angiolillo, Cesare Braggion, et al. 2018. “Trans-Heterozygosity for Mutations Enhances the Risk of Recurrent/Chronic Pancreatitis in Patients with Cystic Fibrosis.” Molecular Medicine 24 (1): 1–10. doi:10.1186/s10020-018-0041-6.